상세 정보

DH Park
Sales Specialist, Reproductive Health and Human Genotyping
Illumina Korea

DH Park received his undergraduate degree in Biomedical Engineering from Tufts University and Master’s degree at Columbia University. He started his career at Macrogen for NGS services sales for Middle East and Japan and co-founded 3billion, before joining illumina in 2018.

At Illumina, DH is in charge of reproductive health and human genotyping segment in Korea. He is passionate about helping customers succeed with genomics technologies in clinical settings.

 

VeriSeq NIPT V2 offers an IVD approved expanded end to end NIPT solution. With expanded content that includes detection of aneuploidies on all chromosomes and sub-chromosomal anomaly over 7 Mb in size, VeriSeq NIPT V2 is a comprehensive NIPT solution. Please join us to learn more about the VeriSeq NIPT v2.

* Please note that this webinar is conducted in Korean language.

Fill Out Form to Access Webinar

귀하의 이메일 주소는 결코 제3자와 공유되지 않습니다.

날짜 및 시간
2020. 7. 15.
02:00 PM
Location
Korea South
Asia
Affiliation
Illumina
Presenter
DH Park
지금 시청하기